Iranian Journal of Neurology 2018. 17(2):.

Interferon-β-1b induced TTP-HUS in a patient treated for multiple sclerosis: a case report
Masoud Etemadifar, Fatemeh Sabeti, Mehri Salari

Abstract


-

Keywords


multiple sclerosis, thrombotic thrombocytopenic purpura, interferon Beta-1

References


Shenkman, B. and Y. Einav, Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. Autoimmun Rev, 2014 - Nangaku, M., H. Nishi, and T. Fujita, Pathogenesis and prognosis of thrombotic microangiopathy. Clin Exp Nephrol, 2007 - Vosoughi, R. and J.J. Marriott, Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: Review of literature and report of two new cases. Multiple Sclerosis and Related Disorders, 2014 - Ben-Amor, A.F., A. Trochanov, and T.Z. Fischer, Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon beta-1a. Adv Ther, 2015 - Moake, J., Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Best Practice & Research Clinical Haematology, 2009


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.